Acadia Pharmaceuticals Gets Raised and 2 More Analyst Upgrades to Read Now
Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!
Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock?s Movement’. Here are catalysts you must know today:
Acadia Pharmaceuticals (NASDAQ:ACAD): Piper Jaffray upgraded its rating on this company from Neutral to Overweight.
Adobe Systems (NASDAQ:ADBE): Goldman Sachs upgraded its rating on this company from Sell to Neutral and changed its price target to $48.00.
Balfour Beatty (NYSE:BBY): Berenberg Bank upgraded its rating on this company to Buy and changed its price target to $4.45.
Don’t Miss: Cyprus Sells Gold to Help Fund Bailout.